Smiths Group PLC

Regulatory Filings • Sep 21, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4787B

Smiths Group PLC

21 September 2018

News Release

London, 21 September 2018

For immediate release

Smiths Group divests Smiths Medical's sterile water bottling business

Smiths Group plc ("Smiths Group" or the "Company") today announces that it has reached an agreement to sell Smiths Medical's sterile water bottling business to Amsino Healthcare (USA), Inc., for an enterprise value of $40m, representing a 4x revenue multiple based on FY18 revenue. The deal is expected to complete in the first half of FY2019.

The divestment demonstrates further progress on the Group's ongoing programme to concentrate the portfolio on scalable market leading positions in the Company's chosen markets. The proceeds will be reinvested in attractive growth opportunities for the Company.

Andy Reynolds Smith, Chief Executive of Smiths Group, said: 

"The sale of this business demonstrates further progress as we focus Smiths Group's portfolio on scalable market leading positions in our chosen markets.

With a strong portfolio of category leading products trusted by clinicians and patients around the world and with over 20 products launched in the last year, we are confident that our strategy for Smiths Medical will drive market outperformance and world-class competitiveness over the medium term."

END

Enquiries:

Investor enquiries
Jemma Spalton, Smiths Group +44 (0)20 7004 1637 +44 (0)78 6739 0350 jemma.spalton@smiths.com	Marion Le Bot, Smiths Group +44 (0)20 7004 1672 +44 (0)75 8315 4386 marion.lebot@smiths.com
Media enquiries
Deborah Scott, FTI Consulting +44 (0)20 3727 1459 +44 (0)797 953 7449 smiths@fticonsulting.com	Alex Le May, FTI Consulting +44 (0)20 3727 1308 +44 (0)7702 443 312 smiths@fticonsulting.com

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

About Smiths Group

Smiths Group is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the medical technology, security & defence, energy, space & commercial aerospace, construction, transportation and general industrial markets worldwide. Smiths Group employs c.22,000 colleagues in over 50 countries. For more information visit www.smiths.com.

About Smiths Medical

Smiths Medical is a leading supplier of specialised medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. For more information visit www.smiths-medical.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DISBCGDCGXDBGIG